Skip to main content
. 2010 Aug;11(8):1284–1293. doi: 10.1111/j.1526-4637.2010.00896.x

Table 7.

Treatment emergent adverse events and the types of adverse events that differed significantly between treatment groups

Placebo (n = 86) 800 mg IV-Ibuprofen (n = 99) Safety population (n = 185) P value
Number of patients experiencing at least one adverse event 74 (86%) 90 (91%) 164 (89%) 0.356
Adverse events that differed significantly between treatment groups
Type of adverse event n % n % N %
Vomiting 12 (14%) 27 (27%) 39 (21%) 0.031
Dyspepsia 4 (5%) 0 0 4 (2%) 0.045